FDA approves cemiplimab-rwlc for non-small cell lung cancer with high PD-L1 expression

Oncology News Burst

Source: FDA Center for Drug Evaluation and Research - What's New - June 11, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news